Parabolan

ACTIVE HALF-LIFE 7 days
CLASSIFICATION Anabolic Steroid
DOSAGE Men: 150-600 mg/week
ACNE Rarely experienced
WATER RETENTION Absent
HBR Not applicable
HEPATOTOXICITY Yes
AROMATIZATION None
MANUFACTURER Hilma Biocare
LAB TEST Available in documentation
WAREHOUSE EU Warehouse 3
SUBSTANCE Trenbolone Hexahydrobenzylcarbonate

Originally developed by Negma Laboratories in France during the late 1960s, Parabolan stands out as the first and only Trenbolone variant approved for human consumption. For several years, it was prescribed to address conditions such as malnutrition, osteoporosis, and cachexia until its market withdrawal in 1997. Trenbolone is celebrated for its potent anabolic and androgenic properties, surpassing even those of Testosterone.

Athletes incorporating Parabolan into their regimen can anticipate remarkable gains in lean muscle mass, heightened strength, and improved oxygen delivery in the bloodstream, facilitating faster recovery of both muscle and bone tissues. Furthermore, it enhances Insulin-Like Growth Factor-1 (IGF-1) levels and supports effective fat loss.

While Parabolan boasts impressive benefits, users may encounter some side effects, including rare acne outbreaks, temporary suppression of natural testosterone levels, elevated Low-Density Lipoprotein (LDL) cholesterol, as well as mood swings, insomnia, and irritability.